AHLERS JAMES M (Chief Financial Officer) received a stock award from CUE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/3/2026ACC: 0001320383-26-000006
Officer· Chief Financial Officer
Since Jul 2026
+76.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
76.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25.50K
Price / share
—
Trade value
—
% of position
New position
7/30/2026
0.00→25.50K
Total
Net shares
+25.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2026 | A · Award | +25.50K | — | — | New position | 0.00 | 25.50K |
| Total | +25.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
51K shares
Shares
+51K
Strike price
30.40
Held after
51K
Exercisable
—
7/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock51K shares | 7/30/2026 | A · Award | +51K | 30.40 | — | 51K |